社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
Leaynx
IP属地:未知
+关注
帖子 · 27
帖子 · 27
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Leaynx
Leaynx
·
2021-12-23
Thanks for sharing
非常抱歉,此主贴已删除
看
729
回复
评论
点赞
4
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-12-07
Go for apple
4 of the Safest Dividend Stocks That'll Help You Crush Inflation
Apple and four other tech stalwarts are well insulated from inflation.
4 of the Safest Dividend Stocks That'll Help You Crush Inflation
看
1,143
回复
评论
点赞
2
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-11-21
ASML[财迷]
非常抱歉,此主贴已删除
看
1,219
回复
3
点赞
5
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-11-18
Wow
Starbucks, Amazon team up to open cashier-less store, cafe in NYC
Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in
Starbucks, Amazon team up to open cashier-less store, cafe in NYC
看
1,127
回复
评论
点赞
5
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-11-13
[强]
Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.
Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo
Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.
看
1,229
回复
评论
点赞
5
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-11-13
Noted with thanks
非常抱歉,此主贴已删除
看
1,229
回复
1
点赞
7
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-10-19
NIO good
非常抱歉,此主贴已删除
看
1,022
回复
1
点赞
8
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-09-30
Nice Starbucks
非常抱歉,此主贴已删除
看
1,558
回复
2
点赞
8
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-09-23
Good
非常抱歉,此主贴已删除
看
857
回复
1
点赞
6
编组 21备份 2
分享
举报
Leaynx
Leaynx
·
2021-09-21
Like
Greenidge Generation Holdings (GREE), Support.com (SPRT) Stock News and Forecast: Why is GREE down?
GREE shares continue to collapse after the merger deal with Support.com (SPRT). GREE stock falls ove
Greenidge Generation Holdings (GREE), Support.com (SPRT) Stock News and Forecast: Why is GREE down?
看
172
回复
评论
点赞
3
编组 21备份 2
分享
举报
加载更多
暂无关注
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3587034259149930","uuid":"3587034259149930","gmtCreate":1623940234980,"gmtModify":1623941703944,"name":"Leaynx","pinyin":"leaynx","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":18,"headSize":449,"tweetSize":27,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":698031802,"gmtCreate":1640257493340,"gmtModify":1640257493571,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3587034259149930","authorIdStr":"3587034259149930"},"themes":[],"htmlText":"Thanks for sharing","listText":"Thanks for sharing","text":"Thanks for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698031802","repostId":"2193422197","repostType":4,"isVote":1,"tweetType":1,"viewCount":729,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606640777,"gmtCreate":1638877145202,"gmtModify":1638877145385,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3587034259149930","authorIdStr":"3587034259149930"},"themes":[],"htmlText":"Go for apple","listText":"Go for apple","text":"Go for apple","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606640777","repostId":"1153880755","repostType":4,"repost":{"id":"1153880755","kind":"news","pubTimestamp":1638867395,"share":"https://www.laohu8.com/m/news/1153880755?lang=&edition=full","pubTime":"2021-12-07 16:56","market":"us","language":"en","title":"4 of the Safest Dividend Stocks That'll Help You Crush Inflation","url":"https://stock-news.laohu8.com/highlight/detail?id=1153880755","media":"Motley Fool","summary":"Apple and four other tech stalwarts are well insulated from inflation.","content":"<p>Rising inflation is wreaking havoc on many high-growth stocks as investors fret over higher costs and reduced future valuations. Higher interest rates, which counter inflation, are also sparking fears of an economic slowdown and causing investors to rotate from dividend stocks toward lower-risk bonds.</p>\n<p>Faced with these challenges, it might seem like a bad idea to buy dividend-paying tech stocks. However, these four tech dividend stocks should remain resilient and easily withstand the upcoming inflation-related challenges.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3710057a11169b9e18f5bf46888ca7fb\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>Image source: Apple.</span></p>\n<p><b>1. Apple</b></p>\n<p><b>Apple</b> only pays a forward dividend yield of 0.5%, but its lowpayout ratioof 15% indicates there's still plenty of room for much higher payments. Apple's stock price has risen nearly 270% over the past three years, but it still doesn't look terribly expensive at 29 times forward earnings.</p>\n<p>Apple is an inflation-resistant company for two simple reasons. First, it has the clout to negotiate more favorable prices from its suppliers. Second, it probably won't lose a lot of its loyal customers if it charges higher prices for its hardware since they're already firmly locked into its software ecosystem.</p>\n<p>Apple has also consistently executed big stock buybacks, which have reduced its outstanding shares by nearly 22% over the past five years. Spending more cash on those buybacks, which boosts the value of its remaining shares, is a better strategy than letting its cash stagnate in an inflationary environment.</p>\n<p>Apple will face a near-term slowdown as it grapples with supply chain constraints, but its long-term outlook is still bright. Its services ecosystem continues to expand, and it will eventually expand into new next-gen markets like augmented reality, virtual reality, and connected cars.</p>\n<p><b>2. Verizon</b></p>\n<p><b>Verizon</b> pays a forward dividend yield of 5%. The telecom giant has raised that dividend annually for 15 straight years, and it's spent less than half of its earnings per share on those payments over the past 12 months. The stock also trades at just nine times forward earnings.</p>\n<p>At first glance, Verizon seems like a lackluster investment. It's declined more than 10% over the past three years as the <b>S&P 500</b> has risen nearly 70%.</p>\n<p>However, Verizon's stock will likely remain stable as rising inflation and higher interest rates rattle the markets. As the largest wireless carrier in the U.S., Verizon can likely pass on most of its higher costs onto consumers without significantly increasing its churn rates. It's also a more streamlined company than <b>AT&T</b>, which is still trying toundo the damageof the debt-fueled expansions of its media and pay-TV ecosystems.</p>\n<p>Verizon's stable returns, sticky ecosystem, high dividend, and low valuation will all make it an ideal safe-haven stock in an inflationary market.</p>\n<p><b>3. Qualcomm</b></p>\n<p><b>Qualcomm</b>, one of the world's largest mobile chipmakers, pays a forward dividend yield of 1.5%. It's raised its annual payout over the past two years, and it's only spent about a third of its earnings on its dividends over the past 12 months.</p>\n<p>Qualcomm's two main businesses are both well-insulated from inflation. Its Snapdragon system on chips (SoCs), which bundle together a mobile CPU, GPU, and baseband modem, power most of the world's high-end smartphones. They can also be found in virtual reality headsets, cars, and drones. The secular growth of those markets will give Qualcomm plenty of pricing power.</p>\n<p>Its licensing business, which leverages its portfolio of wireless patents to earn a cut of every smartphone sold worldwide, also generates a stable stream of high-margin revenue. It then plows a large portion of that excess cash into big buybacks and dividends.</p>\n<p>Qualcomm's stock has already risen more than 200% as investors have recognized those long-term strengths, but it still looks cheap at 17 times forward earnings.</p>\n<p><b>4. Texas Instruments</b></p>\n<p><b>Texas Instruments</b> manufactures a wide range of analog and embedded chips for consumer electronics, cars, industrial machines, and other markets. These chips aren't as powerful as Qualcomm's mobile chips, but they're just as essential and less capital-intensive to produce.</p>\n<p>Unlike Qualcomm, which outsources the production of its chips to third-party foundries, TI manufactures its own chips in-house. That business model insulates it from the ongoing chip shortage, and its cost-cutting migration from 200mm to 300mm wafers over the past few years enabled it to significantly reduce its own manufacturing costs and boost its gross margins.</p>\n<p>TI's business is naturally resistant to inflation since it has much better control over its own supply chain and operating expenses than other chipmakers, and it generates plenty of excess cash for buybacks and dividends. It reduced its number of outstanding shares by 46% between 2004 and 2020, and it's raised its dividend annually for 18 straight years. It currently pays a forward dividend yield of 2.4%, which is supported by a sustainable payout ratio of 52%.</p>\n<p>TI's stock has more than doubled over the past three years, but it still trades at 23 times forward earnings. That reasonable valuation, along with its healthy yield and stable business, makes TI a reliable and inflation-resistant tech stock.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 of the Safest Dividend Stocks That'll Help You Crush Inflation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 of the Safest Dividend Stocks That'll Help You Crush Inflation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 16:56 GMT+8 <a href=https://www.fool.com/investing/2021/12/06/safe-dividend-stocks-that-help-crush-inflation/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rising inflation is wreaking havoc on many high-growth stocks as investors fret over higher costs and reduced future valuations. Higher interest rates, which counter inflation, are also sparking fears...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/06/safe-dividend-stocks-that-help-crush-inflation/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/12/06/safe-dividend-stocks-that-help-crush-inflation/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153880755","content_text":"Rising inflation is wreaking havoc on many high-growth stocks as investors fret over higher costs and reduced future valuations. Higher interest rates, which counter inflation, are also sparking fears of an economic slowdown and causing investors to rotate from dividend stocks toward lower-risk bonds.\nFaced with these challenges, it might seem like a bad idea to buy dividend-paying tech stocks. However, these four tech dividend stocks should remain resilient and easily withstand the upcoming inflation-related challenges.\nImage source: Apple.\n1. Apple\nApple only pays a forward dividend yield of 0.5%, but its lowpayout ratioof 15% indicates there's still plenty of room for much higher payments. Apple's stock price has risen nearly 270% over the past three years, but it still doesn't look terribly expensive at 29 times forward earnings.\nApple is an inflation-resistant company for two simple reasons. First, it has the clout to negotiate more favorable prices from its suppliers. Second, it probably won't lose a lot of its loyal customers if it charges higher prices for its hardware since they're already firmly locked into its software ecosystem.\nApple has also consistently executed big stock buybacks, which have reduced its outstanding shares by nearly 22% over the past five years. Spending more cash on those buybacks, which boosts the value of its remaining shares, is a better strategy than letting its cash stagnate in an inflationary environment.\nApple will face a near-term slowdown as it grapples with supply chain constraints, but its long-term outlook is still bright. Its services ecosystem continues to expand, and it will eventually expand into new next-gen markets like augmented reality, virtual reality, and connected cars.\n2. Verizon\nVerizon pays a forward dividend yield of 5%. The telecom giant has raised that dividend annually for 15 straight years, and it's spent less than half of its earnings per share on those payments over the past 12 months. The stock also trades at just nine times forward earnings.\nAt first glance, Verizon seems like a lackluster investment. It's declined more than 10% over the past three years as the S&P 500 has risen nearly 70%.\nHowever, Verizon's stock will likely remain stable as rising inflation and higher interest rates rattle the markets. As the largest wireless carrier in the U.S., Verizon can likely pass on most of its higher costs onto consumers without significantly increasing its churn rates. It's also a more streamlined company than AT&T, which is still trying toundo the damageof the debt-fueled expansions of its media and pay-TV ecosystems.\nVerizon's stable returns, sticky ecosystem, high dividend, and low valuation will all make it an ideal safe-haven stock in an inflationary market.\n3. Qualcomm\nQualcomm, one of the world's largest mobile chipmakers, pays a forward dividend yield of 1.5%. It's raised its annual payout over the past two years, and it's only spent about a third of its earnings on its dividends over the past 12 months.\nQualcomm's two main businesses are both well-insulated from inflation. Its Snapdragon system on chips (SoCs), which bundle together a mobile CPU, GPU, and baseband modem, power most of the world's high-end smartphones. They can also be found in virtual reality headsets, cars, and drones. The secular growth of those markets will give Qualcomm plenty of pricing power.\nIts licensing business, which leverages its portfolio of wireless patents to earn a cut of every smartphone sold worldwide, also generates a stable stream of high-margin revenue. It then plows a large portion of that excess cash into big buybacks and dividends.\nQualcomm's stock has already risen more than 200% as investors have recognized those long-term strengths, but it still looks cheap at 17 times forward earnings.\n4. Texas Instruments\nTexas Instruments manufactures a wide range of analog and embedded chips for consumer electronics, cars, industrial machines, and other markets. These chips aren't as powerful as Qualcomm's mobile chips, but they're just as essential and less capital-intensive to produce.\nUnlike Qualcomm, which outsources the production of its chips to third-party foundries, TI manufactures its own chips in-house. That business model insulates it from the ongoing chip shortage, and its cost-cutting migration from 200mm to 300mm wafers over the past few years enabled it to significantly reduce its own manufacturing costs and boost its gross margins.\nTI's business is naturally resistant to inflation since it has much better control over its own supply chain and operating expenses than other chipmakers, and it generates plenty of excess cash for buybacks and dividends. It reduced its number of outstanding shares by 46% between 2004 and 2020, and it's raised its dividend annually for 18 straight years. It currently pays a forward dividend yield of 2.4%, which is supported by a sustainable payout ratio of 52%.\nTI's stock has more than doubled over the past three years, but it still trades at 23 times forward earnings. That reasonable valuation, along with its healthy yield and stable business, makes TI a reliable and inflation-resistant tech stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872868915,"gmtCreate":1637477026700,"gmtModify":1637477026843,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3587034259149930","authorIdStr":"3587034259149930"},"themes":[],"htmlText":"ASML[财迷] ","listText":"ASML[财迷] ","text":"ASML[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/872868915","repostId":"2184782893","repostType":4,"isVote":1,"tweetType":1,"viewCount":1219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878786455,"gmtCreate":1637233520376,"gmtModify":1637233520462,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3587034259149930","authorIdStr":"3587034259149930"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878786455","repostId":"1171955198","repostType":4,"repost":{"id":"1171955198","kind":"news","pubTimestamp":1637233373,"share":"https://www.laohu8.com/m/news/1171955198?lang=&edition=full","pubTime":"2021-11-18 19:02","market":"us","language":"en","title":"Starbucks, Amazon team up to open cashier-less store, cafe in NYC","url":"https://stock-news.laohu8.com/highlight/detail?id=1171955198","media":"Yahoo","summary":"Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in ","content":"<p>Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.</p>\n<p>The new Starbucks Pickup, located at 59th Street between Park & Lexington Avenue, is set to open to the public on Thursday, November 18th. The retail experience uses the order ahead feature on the Starbucks app and Amazon Go’s Just Walk Out technology to create a touch-less experience, the companies announced on Thursday.</p>\n<p>The team-up is part of the ongoing COVID-19 era trend to leverage technology in favor of human contact to expedite requests, as well as reduce the chances of transmission.</p>\n<p>The two powerhouses are teaming up to create \"a common vision to provide innovative in-store experiences that are centered on the customer,” Dilip Kumar, Amazon's VP of physical retail and technology, said in a statement.</p>\n<p>Dubbed Starbucks Pickup with Amazon Go, the system gives customers the ability to choose their experience, \"whether it is utilizing the Starbucks and Amazon apps to purchase food and beverages on the go, or deciding to stay in the lounge for the traditional third place experience Starbucks is known for,” Starbucks executive Katie Young said.</p>\n<p>In order to enter the Amazon GO market and the store's lounge area, they must scan the \"In-Store Code\" in the Amazon Shopping app, Amazon One or a credit card. Once consumers enter the location, they can shop the market like any other Amazon Go location, grab their Starbucks mobile order and leave — or choose to stay a while.</p>\n<p>When guests take any item off the shelf, it will immediately be added to their virtual cart, and if customers put back an item, it will come out of the cart. Once the customer leaves the Amazon Go market portion of the store, their card will be charged and the receipt is expected to follow within a few hours, if not faster, according to the release.</p>\n<p>Items that will be available for pickup include classic Starbucks fare like Sous Vide Egg Bites, breakfast sandwiches and protein boxes, in addition to items that are found at other Amazon Go locations. Those include its Kitchen Turkey and Cheddar Sandwich, and the Buffalo-Style Wrap.</p>\n<p>In addition to that, the shelves will be stocked with well-known local favorites with items from Genji Sushi, York Street, Magnolia Bakery, Ess-a-bagel, among others.</p>\n<p>As Starbucks dives headfirst into digital and its loyalty program use soars, the companies plan to open at least three Starbucks Pickup with Amazon Go stores in total within the coming year, with the second location set to open in The New York Times Building located at 40th Street & 8th Avenue.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starbucks, Amazon team up to open cashier-less store, cafe in NYC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarbucks, Amazon team up to open cashier-less store, cafe in NYC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 19:02 GMT+8 <a href=https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html><strong>Yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.\nThe new Starbucks Pickup, located at 59th Street between ...</p>\n\n<a href=\"https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克","AMZN":"亚马逊"},"source_url":"https://finance.yahoo.com/news/starbucks-amazon-go-open-cashier-less-store-and-cafe-in-new-york-city-100021204.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171955198","content_text":"Starbucks (SBUX) has teamed up with Amazon (AMZN) Go to deliver a new store concept to consumers in New York City — one without any cashiers.\nThe new Starbucks Pickup, located at 59th Street between Park & Lexington Avenue, is set to open to the public on Thursday, November 18th. The retail experience uses the order ahead feature on the Starbucks app and Amazon Go’s Just Walk Out technology to create a touch-less experience, the companies announced on Thursday.\nThe team-up is part of the ongoing COVID-19 era trend to leverage technology in favor of human contact to expedite requests, as well as reduce the chances of transmission.\nThe two powerhouses are teaming up to create \"a common vision to provide innovative in-store experiences that are centered on the customer,” Dilip Kumar, Amazon's VP of physical retail and technology, said in a statement.\nDubbed Starbucks Pickup with Amazon Go, the system gives customers the ability to choose their experience, \"whether it is utilizing the Starbucks and Amazon apps to purchase food and beverages on the go, or deciding to stay in the lounge for the traditional third place experience Starbucks is known for,” Starbucks executive Katie Young said.\nIn order to enter the Amazon GO market and the store's lounge area, they must scan the \"In-Store Code\" in the Amazon Shopping app, Amazon One or a credit card. Once consumers enter the location, they can shop the market like any other Amazon Go location, grab their Starbucks mobile order and leave — or choose to stay a while.\nWhen guests take any item off the shelf, it will immediately be added to their virtual cart, and if customers put back an item, it will come out of the cart. Once the customer leaves the Amazon Go market portion of the store, their card will be charged and the receipt is expected to follow within a few hours, if not faster, according to the release.\nItems that will be available for pickup include classic Starbucks fare like Sous Vide Egg Bites, breakfast sandwiches and protein boxes, in addition to items that are found at other Amazon Go locations. Those include its Kitchen Turkey and Cheddar Sandwich, and the Buffalo-Style Wrap.\nIn addition to that, the shelves will be stocked with well-known local favorites with items from Genji Sushi, York Street, Magnolia Bakery, Ess-a-bagel, among others.\nAs Starbucks dives headfirst into digital and its loyalty program use soars, the companies plan to open at least three Starbucks Pickup with Amazon Go stores in total within the coming year, with the second location set to open in The New York Times Building located at 40th Street & 8th Avenue.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873905868,"gmtCreate":1636817095910,"gmtModify":1636817096030,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3587034259149930","authorIdStr":"3587034259149930"},"themes":[],"htmlText":"[强] ","listText":"[强] ","text":"[强]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873905868","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8 <a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873905136,"gmtCreate":1636817047789,"gmtModify":1636817047907,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3587034259149930","authorIdStr":"3587034259149930"},"themes":[],"htmlText":"Noted with thanks","listText":"Noted with thanks","text":"Noted with thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873905136","repostId":"2182018576","repostType":4,"isVote":1,"tweetType":1,"viewCount":1229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850729969,"gmtCreate":1634629861937,"gmtModify":1634629867914,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3587034259149930","authorIdStr":"3587034259149930"},"themes":[],"htmlText":"NIO good","listText":"NIO good","text":"NIO good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/850729969","repostId":"2176482124","repostType":2,"isVote":1,"tweetType":1,"viewCount":1022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865166241,"gmtCreate":1632961733831,"gmtModify":1632961734080,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3587034259149930","authorIdStr":"3587034259149930"},"themes":[],"htmlText":"Nice Starbucks","listText":"Nice Starbucks","text":"Nice Starbucks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/865166241","repostId":"2171438933","repostType":2,"isVote":1,"tweetType":1,"viewCount":1558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863274190,"gmtCreate":1632403959010,"gmtModify":1632732584892,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3587034259149930","authorIdStr":"3587034259149930"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/863274190","repostId":"2169608546","repostType":2,"isVote":1,"tweetType":1,"viewCount":857,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869978430,"gmtCreate":1632239090320,"gmtModify":1632801826388,"author":{"id":"3587034259149930","authorId":"3587034259149930","name":"Leaynx","avatar":"https://static.tigerbbs.com/40fef3ce50949e248e90fd9930d8a0b7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3587034259149930","authorIdStr":"3587034259149930"},"themes":[],"htmlText":"Like ","listText":"Like ","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/869978430","repostId":"1140143812","repostType":4,"repost":{"id":"1140143812","kind":"news","pubTimestamp":1632233062,"share":"https://www.laohu8.com/m/news/1140143812?lang=&edition=full","pubTime":"2021-09-21 22:04","market":"us","language":"en","title":"Greenidge Generation Holdings (GREE), Support.com (SPRT) Stock News and Forecast: Why is GREE down?","url":"https://stock-news.laohu8.com/highlight/detail?id=1140143812","media":"fxstreet","summary":"GREE shares continue to collapse after the merger deal with Support.com (SPRT).\nGREE stock falls ove","content":"<ul>\n <li><b>GREE shares continue to collapse after the merger deal with Support.com (SPRT).</b></li>\n <li><b>GREE stock falls over 20% on Monday.</b></li>\n <li><b>Equity markets suffer, but retail names really fall as volatility is high.</b></li>\n</ul>\n<p>GREE shares continue to make a name for themselves for all the wrong reasons as the calamitous fall continues on Monday. Things were already bleak for those long from the old SPRT ticker, but since GREE took over things have gone from bad to worse. GREE fell another 22% on Monday to close just over $30. GREE peaked at $60 last week and so had lost half of its value in just four trading sessions. What investors and traders must be wondering is how much more pain is to come?</p>\n<p>GREE stock news</p>\n<p>Just as a back story, GREE was formed as Greenidge Generation Holdings took over Support.com. Support.com had traded under the ticker SPRT and was a meme stock favourite with a large retail following enthusiastically discussing the stock on social media. SPRT stock had exhibited huge price swings just as with a lot of other retail or meme names. Back in March of this year is when things started to get interesting and when retail traders started to really notice the stock. The deal with Greenidge was announced in March. Support.com was a good fit for retail traders as it was a facilitator of remote working solutions, which grew in popularity during the pandemic. However, Support.com is a much smaller entity despite having a public listing.</p>\n<p>After the merger, Support.com became a small part or subsidiary of Greenidge. SPRT shares spiked on the announcement of this deal back in March but went quiet again until retail interest appeared to pick up in August. SPRT stock was circulating around various social media chat sites as the short interest was high, meaning the retail traders decided to try and instigate a short squeeze. This has obviously worked well in other meme names such as GME and AMC, but SPRT was not exactly in the same situation. SPRTstockwas to become a much smaller piece of the overall GREE company. There have also been valuation concerns that the SPRT spike had put a much too high valuation on the combined GREE company. Investors sold as a result. Usually in a merger or takeover, positions in the old ticker are rolled into the new one.</p>\n<p>GREE stock forecast</p>\n<p>As we can see from the chart below, the point of control since GREE launched is at $47.56 with the Volume Weighted Average Price (VWAP) just below at $43. This is a volume resistance then as most of the volume has been here. There is not much historical data to look through for the chart otherwise, and thevolatilitymakes anyanalysisrather difficult. Please use risk control in all names, but particularily one as volatile as this.</p>\n<p><img src=\"https://static.tigerbbs.com/4002c7efb50cc1afa912ddea168ab7b7\" tg-width=\"2097\" tg-height=\"1200\" referrerpolicy=\"no-referrer\"></p>\n<p>Greenidge Generation falls nearly 9% in morning trading.<img src=\"https://static.tigerbbs.com/1cb93fe02339099c8852eaa00d07bd9d\" tg-width=\"1185\" tg-height=\"583\" width=\"100%\" height=\"auto\"></p>","source":"lsy1617153743470","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Greenidge Generation Holdings (GREE), Support.com (SPRT) Stock News and Forecast: Why is GREE down?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGreenidge Generation Holdings (GREE), Support.com (SPRT) Stock News and Forecast: Why is GREE down?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 22:04 GMT+8 <a href=https://www.fxstreet.com/news/greenidge-generation-holdings-gree-supportcom-sprt-stock-news-and-forecast-why-is-gree-down-202109211205><strong>fxstreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GREE shares continue to collapse after the merger deal with Support.com (SPRT).\nGREE stock falls over 20% on Monday.\nEquity markets suffer, but retail names really fall as volatility is high.\n\nGREE ...</p>\n\n<a href=\"https://www.fxstreet.com/news/greenidge-generation-holdings-gree-supportcom-sprt-stock-news-and-forecast-why-is-gree-down-202109211205\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GREE":"Greenidge Generation Holdings Inc."},"source_url":"https://www.fxstreet.com/news/greenidge-generation-holdings-gree-supportcom-sprt-stock-news-and-forecast-why-is-gree-down-202109211205","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140143812","content_text":"GREE shares continue to collapse after the merger deal with Support.com (SPRT).\nGREE stock falls over 20% on Monday.\nEquity markets suffer, but retail names really fall as volatility is high.\n\nGREE shares continue to make a name for themselves for all the wrong reasons as the calamitous fall continues on Monday. Things were already bleak for those long from the old SPRT ticker, but since GREE took over things have gone from bad to worse. GREE fell another 22% on Monday to close just over $30. GREE peaked at $60 last week and so had lost half of its value in just four trading sessions. What investors and traders must be wondering is how much more pain is to come?\nGREE stock news\nJust as a back story, GREE was formed as Greenidge Generation Holdings took over Support.com. Support.com had traded under the ticker SPRT and was a meme stock favourite with a large retail following enthusiastically discussing the stock on social media. SPRT stock had exhibited huge price swings just as with a lot of other retail or meme names. Back in March of this year is when things started to get interesting and when retail traders started to really notice the stock. The deal with Greenidge was announced in March. Support.com was a good fit for retail traders as it was a facilitator of remote working solutions, which grew in popularity during the pandemic. However, Support.com is a much smaller entity despite having a public listing.\nAfter the merger, Support.com became a small part or subsidiary of Greenidge. SPRT shares spiked on the announcement of this deal back in March but went quiet again until retail interest appeared to pick up in August. SPRT stock was circulating around various social media chat sites as the short interest was high, meaning the retail traders decided to try and instigate a short squeeze. This has obviously worked well in other meme names such as GME and AMC, but SPRT was not exactly in the same situation. SPRTstockwas to become a much smaller piece of the overall GREE company. There have also been valuation concerns that the SPRT spike had put a much too high valuation on the combined GREE company. Investors sold as a result. Usually in a merger or takeover, positions in the old ticker are rolled into the new one.\nGREE stock forecast\nAs we can see from the chart below, the point of control since GREE launched is at $47.56 with the Volume Weighted Average Price (VWAP) just below at $43. This is a volume resistance then as most of the volume has been here. There is not much historical data to look through for the chart otherwise, and thevolatilitymakes anyanalysisrather difficult. Please use risk control in all names, but particularily one as volatile as this.\n\nGreenidge Generation falls nearly 9% in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":false}